Biocomposites, Ltd. · Class II · Cleared Feb 4, 2022
| K-number | K212721 |
| Device name | Genex Bone Graft Substitute |
| Applicant | Biocomposites, Ltd. |
| Product code | MQV |
| Device class | Class II |
| Decision date | Feb 4, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 888.3045 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov